Profile data is unavailable for this security.
About the company
Toho Holdings Co Ltd is a Japan-based company mainly engaged in the pharmaceutical wholesale business. The Company operates through five business segments. The Pharmaceutical Wholesale segment purchases pharmaceuticals and medical-related products from pharmaceutical manufacturers and sells them to hospitals, clinics and dispensing pharmacies. It is also engaged in the provision of data processing system and rental of real estate. The Dispensing Pharmacy segment is engaged in the management of insurance dispensing pharmacies and dispensing pharmacies. The Pharmaceutical Manufacture and Sale segment is engaged in the manufacture and sale of generic drugs and contract manufacturing of injectable drugs. The Clinical Trial Facility Support segment is engaged in the provision of support for clinical trial facilities. The Information Equipment Sales segment is engaged in the planning and sale of information processing equipment.
- Revenue in JPY (TTM)1.45tn
- Net income in JPY17.57bn
- Incorporated1948
- Employees7.70k
- LocationToho Holdings Co Ltd5-2-1, DaizawaSETAGAYA-KU 155-8655JapanJPN
- Phone+81 334197811
- Fax+81 334146042
- Websitehttps://www.tohohd.co.jp/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selcuk Ecza Deposu Ticaret ve Sanayi AS | 464.60bn | 1.06bn | 163.13bn | 6.03k | 153.71 | 2.28 | 53.56 | 0.3511 | 0.3594 | 0.3594 | 157.36 | 24.25 | 2.30 | 10.73 | 10.42 | 16,218,930.00 | 0.5255 | 3.16 | 1.41 | 8.40 | 9.38 | 9.37 | 0.2284 | 1.24 | 1.05 | -- | 0.1382 | 27.16 | 14.70 | 48.64 | -64.89 | -10.62 | 23.13 | 20.11 |
Guangxi LiuYao Group Co Ltd | 436.97bn | 17.11bn | 166.49bn | 5.16k | 9.73 | 1.20 | -- | 0.381 | 2.21 | 2.21 | 56.44 | 17.97 | 1.02 | 7.66 | 1.96 | 3,961,076.00 | 4.36 | 5.37 | 11.45 | 12.66 | 11.26 | 11.68 | 4.27 | 4.48 | 1.26 | 6.34 | 0.5641 | 30.45 | 11.19 | 15.06 | 24.42 | 11.81 | -0.6923 | 8.57 |
DocMorris AG | 164.61bn | -19.96bn | 195.18bn | 1.45k | -- | 2.29 | -- | 1.19 | -10.07 | 7.03 | 83.05 | 36.60 | 0.9863 | 11.36 | 10.50 | 667,214.10 | -11.96 | -12.92 | -15.23 | -15.74 | 20.98 | 16.84 | -12.13 | -10.87 | 1.34 | -2.39 | 0.4448 | -- | 4.13 | -4.29 | 31.29 | -- | -2.53 | -- |
Sigma Healthcare Ltd | 343.18bn | 452.82m | 214.69bn | 156.00 | 331.65 | 2.36 | 63.56 | 0.6256 | 0.004 | 0.004 | 3.34 | 0.5544 | 2.68 | 11.37 | 10.52 | -- | 0.4162 | 0.5734 | 0.625 | 0.9762 | 9.17 | 9.52 | 0.1554 | 0.2022 | 1.86 | 1.59 | 0.1354 | 184.52 | -9.16 | -3.46 | 148.98 | -34.19 | -46.55 | -21.93 |
Tibet Rhodiola Pharmaceutical Holding Co | 66.98bn | 17.12bn | 253.01bn | 601.00 | 14.78 | 3.54 | -- | 3.78 | 3.23 | 3.23 | 12.64 | 13.49 | 0.7216 | 1.83 | 5.71 | 5,215,189.00 | 18.65 | 12.44 | 25.21 | 15.71 | 93.83 | 90.51 | 25.85 | 20.43 | 2.78 | 7.59 | 0.1294 | 50.41 | 22.69 | 24.98 | 116.56 | 30.01 | -1.48 | 48.97 |
GuangYuYuan Chinese Herbal Medicn Co Ltd | 23.75bn | -6.93bn | 253.15bn | 1.95k | -- | 6.86 | -- | 10.66 | -0.6628 | -0.6628 | 2.27 | 3.53 | 0.4005 | 0.8061 | 1.31 | 569,846.60 | -12.26 | -1.17 | -16.80 | -1.67 | 69.24 | 71.94 | -30.62 | -3.27 | 1.55 | -18.71 | 0.1474 | -- | 16.44 | -3.17 | -26.08 | -- | -50.29 | -- |
Toho Holdings Co Ltd | 1.45tn | 17.57bn | 281.88bn | 7.70k | 15.23 | 0.9626 | 11.64 | 0.1944 | 242.08 | 242.08 | 20,008.50 | 3,831.19 | 1.81 | 14.05 | 4.05 | 188,375,100.00 | 2.20 | 1.83 | 6.09 | 4.35 | 7.94 | 8.60 | 1.21 | 0.9786 | 1.05 | -- | 0.1298 | 18.14 | 9.67 | 2.73 | 1.88 | -1.07 | -22.49 | 1.30 |
China Medical System Holdings Ltd | 171.32bn | 51.33bn | 344.05bn | 5.70k | 6.70 | 1.04 | 6.16 | 2.01 | 1.06 | 1.06 | 3.54 | 6.85 | 0.4517 | 3.42 | 6.19 | 1,520,575.00 | 13.44 | 18.44 | 15.70 | 21.14 | 76.24 | 75.47 | 29.76 | 34.26 | 3.98 | -- | 0.0772 | 40.14 | -12.43 | 8.08 | -26.33 | 5.35 | 38.69 | 5.19 |
China Meheco Group Co Ltd | 864.91bn | 12.03bn | 347.49bn | 8.31k | 28.88 | 1.45 | -- | 0.4018 | 0.3764 | 0.3764 | 27.05 | 7.48 | 1.13 | 5.58 | 2.76 | 4,868,542.00 | 2.05 | 4.09 | 4.44 | 9.37 | 11.07 | 15.92 | 1.81 | 3.38 | 1.16 | 21.23 | 0.3262 | 38.19 | 3.75 | 4.37 | 13.70 | -10.94 | 12.63 | -4.53 |
Suzuken Co Ltd | 2.37tn | 27.68bn | 355.74bn | 13.43k | 13.58 | 0.8739 | 9.78 | 0.150 | 336.97 | 336.97 | 28,802.96 | 5,236.47 | 1.82 | 12.94 | 4.05 | 176,574,900.00 | 2.12 | 1.77 | 6.33 | 4.64 | 7.75 | 8.05 | 1.17 | 0.9199 | 0.9883 | -- | 0.00 | 31.44 | 3.38 | 1.74 | 41.35 | 1.57 | 17.43 | 5.92 |
Holder | Shares | % Held |
---|---|---|
The Vanguard Group, Inc.as of 05 Apr 2024 | 1.90m | 2.48% |
Nomura Asset Management Co., Ltd.as of 30 Nov 2023 | 1.83m | 2.39% |
Norges Bank Investment Managementas of 31 Dec 2023 | 1.33m | 1.74% |
Dimensional Fund Advisors LPas of 04 Apr 2024 | 1.21m | 1.58% |
Nikko Asset Management Co., Ltd.as of 05 Apr 2024 | 835.90k | 1.09% |
Daiwa Asset Management Co. Ltd.as of 29 Mar 2024 | 817.50k | 1.07% |
BlackRock Fund Advisorsas of 04 Apr 2024 | 812.50k | 1.06% |
Mitsubishi UFJ Asset Management Co., Ltd.as of 05 Apr 2024 | 506.00k | 0.66% |
American Century Investment Management, Inc.as of 04 Apr 2024 | 445.40k | 0.58% |
Charles Schwab Investment Management, Inc.as of 04 Apr 2024 | 364.61k | 0.48% |